Viking Therapeutics Inc

VKTXNASDAQ · USD
31.81USD0.00 (-3.70%)
129

Viking Therapeutics Inc (VKTX) Unusual Options Activity Today

VKTX options volume power reached 38x on the previous trading day. The highest reading was on the $44.5 CALL expiring 2026-10-02.

Read more

Checking VKTX unusual options activity helps you spot when traders are making outsized bets on Viking Therapeutics Inc before the broader market catches on. Viking Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor VKTX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching VKTX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking VKTX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and VKTX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy.

The company was incorporated in 2012 and is headquartered in San Diego, California.

Catalysts rarely arrive without a footprint, and VKTX unusual options activity is often where that footprint shows up first. Our scanner tracks Viking Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at VKTX unusual options volume on the call side or chasing put sweeps, Viking Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-02
Calls
32.500.051.010.5376%285142,035.71%
27.503.905.604.75183%6651,320.00%
28.003.205.654.43192%264650.00%
30.501.273.052.16132%22239569.23%
27.004.306.655.48232%4710470.00%
Puts
29.500.040.330.1987%1,046214,980.95%
31.000.420.550.4978%2,296653,532.31%
30.500.110.850.4895%344331,042.42%
31.500.370.830.6070%6435182.86%
24.50—0.690.69321%1010100.00%

As of September 29, 2026

Spot unusual options activity before it moves

Track VKTX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial